Back to all Current clinical trials
Back to all Current clinical trials
INX-315-01
This study will investigate the use of a new medicine called INX-315 which may be used in the future as a possible treatment for advanced solid tumours.
- Category
-
Trial status
Recruiting
-
Trial phase
Phase 1 Drug TrialEarly stage studies seeking initial evidence of safety, dosage and efficacy in small numbers of patients or healthy volunteers.
- Registry listing
-
ERM Project ID
94092
Trial contact details
-
Contact person
Caitlin Bennett
-
Phone
07 3163 7689
What you need to know
Who can take part?
Patients with advanced solid tumour and standard therapy has either been exhausted or is not available
What is involved for you?
The study drug is in a tablet form that you take on a daily basis. You will be required to attend the clinic at least every 1-2 weeks in the first three months of treatment for a physical assessment, blood tests, ECGs and ongoing assessments. You will also receive ongoing tumour assessments via scans.
